Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: January 22, 2007
Last updated: September 15, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2001
  Primary Completion Date: July 2001 (Final data collection date for primary outcome measure)